Teva Pharmaceutical (TEVA) Says Azilec Met Primary Endpoint in Study
Go back to Teva Pharmaceutical (TEVA) Says Azilec Met Primary Endpoint in Study| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 13.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.25 | 52 Week High | $66.55 | |||
| Open | $13.25 | 52 Week Low | $37.82 | |||
| Day High | $13.25 | P/E | N/A | |||
| Day Low | $13.25 | EPS | $0.00 | |||
| Volume | 468 | |||||
